Back to School: How biopharma can reboot drug development. Access exclusive analysis here

HspE7: Phase I

In a dose-ranging study involving 24 healthy volunteers, a single

Read the full 104 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE